Boehringer's Respimat nabs FDA approval for COPD; Pacira shares drop on FDA promo warning;

@FiercePharma: Judge tosses RICO claims over AbbVie's Humira, AndroGel copay cards: | Follow @FiercePharma

@EricPFierce: ICYMI: Mylan proposes plan to avoid nitroglycerin shortage in Canada. Story | Follow @EricPFierce

> Boehringer Ingelheim said its inhaled drug for chronic obstructive pulmonary disease, Spiriva Respimat, won approval from the FDA, with a launch expected in January. Release

> The FDA slapped Pacira Pharmaceuticals ($PCRX) for overstating the benefits of its pain drug Exparel, calling the claims "misleading." Report

> Actavis ($ACT) said Purdue Pharma sued it for patent infringement after it asked the FDA to approve generic versions of Purdue's buprenorphine patch, Butrans. Report

> Indian business leaders challenged the American Enterprise Institute, a conservative think tank, for what they called a "smear campaign" against its pharma industry. Release

> GlaxoSmithKline ($GSK) won approval from local planning officials for its new biopharma facility in Ulverston, U.K., which is expected to create 700-plus jobs. Report

> Rabies experts unveiled a plan to eliminate the disease via mass dog vaccinations in certain regions. Report

Medical Device News

@FierceMedDev: ICYMI yesterday: HealthKit pulled from iPhone 6 after update crashes customers' phones. Article | Follow @FierceMedDev

@MichaelGFierce: Purdue team recreates tumor microenvironment to study cancer nanomed delivery. FierceDrugDelivery story | Follow @MichaelGFierce

@VarunSaxena2: Titan Pharma trial of implant for addicts on track. Story | Follow @VarunSaxena2

@EmilyWFierce: FDA OKs "tumor paint" made from scorpion venom for Phase I clinical trial. Article | Follow @EmilyWFierce

> DOD awards $67M in contracts to Zoll, Philips. Item

> Researchers develop noninvasive device to monitor brain blood flow. Story

> Former AdvaMed board chairman, eye care company CEO accused of insider trading. Article

Biotech News

@FierceBiotech: Biosimilars outfit Coherus pitches an $86M IPO, targeting Enbrel and Humira. More | Follow @FierceBiotech

@JohnCFierce: FierceBiotech's 2014 Fierce 15 - Still trending, all week long. Ain't it cool? Report | Follow @JohnCFierce

@DamianFierce: Tomorrow is FDA decision date No. 4 for $ALIM and $PSDV's Iluvien, if you're into that sort of thing. Both trading up at the moment. | Follow @DamianFierce

@EmilyMFierce: How is it that only one person has been cured of #HIV? A new monkey study reveals clues. Story | Follow @EmilyMFierce

> GSK taps Royal Bank of Scotland chair Philip Hampton to lead its own board. Chutes & Ladders

> Takeda pours $25M into biotech dealmaker BioMotiv. News

> Gilead nears EU approval for the next big thing in hep C. More

And Finally... An outbreak of enterovirus respiratory infections in the Midwest is spreading, baffling scientists. Report